SSI Strategy’s cover photo
SSI Strategy

SSI Strategy

Business Consulting and Services

Parsippany, New Jersey 4,440 followers

Building Better Biotechs

About us

At SSI Strategy, we're strategic partners deeply invested in our clients' success. We offer a unique, adaptive approach to supporting biotech companies, integrating business acumen with deep expertise in Clinical Development & Operations, Regulatory affairs, Pharmacovigilance, Medical Affairs, Quality and more. Our agile skills and resources model allows us to adapt to your specific needs, working as an embedded team within your organization. We complement your existing teams, scaling specialized skill sets up and down as needed, while equipping them with the tools and resources to operate at peak performance. By fostering the organization you want to build, we position your full-time employees to be more successful and effective in their strengths. As your needs evolve, so does our support. We offer deep expertise, strategic insight, and a comprehensive range of services to help you navigate the challenges of bringing a therapeutic from concept to commercialization. Our mission is clear: Build better biotechs through seamless collaboration, informed decision-making, and accelerated progress.

Industry
Business Consulting and Services
Company size
51-200 employees
Headquarters
Parsippany, New Jersey
Type
Privately Held
Founded
2010
Specialties
Pharmacovigilance, Medical Affairs, Drug Safety, Drug Launch, Project Management, Strategic Consulting, Clinical Development, Medical Planning, Regulatory Affairs, Strategic Communications, Quality , and Patient Safety

Locations

Employees at SSI Strategy

Updates

  • Have you been following our 5-part webinar series: Navigating the New EU HTA Regulation with Confidence? Our experts have been guiding you through the evolving EU HTA regulation. From setting the stage in our first webinar, to sharing expert strategies for success, and most recently, exploring Joint Clinical Assessments (JCA) in practice. Don’t miss Part 4 of 5: The EU HTA Regulation: Joint Scientific Consultation – Key Steps, Timing & Strategy 📅 June 5th (registration details coming soon) All webinars are available on our website.

  • Building the Backbone of Biotech Success Leadership in biotech is a team effort. Our latest insights show that when CMOs are backed by a strong, functional Medical Office, they can drive innovation and achieve greater impact. At SSI Strategy, we deliver tailored solutions that streamline operations and empower leaders to focus on what matters most. Discover how we can help you create lasting success. Let’s connect: letstalk@ssistrategy.com #BiotechLeadership #MedicalOffice #CMO #Innovation

  • Have you ever wondered how to flip budget limitations into a launchpad for success? Join our SVP Jennifer Seda and an esteemed panel—featuring Luke Devey, PhD, MD of Quell Therapeutics; John Goldberg, MD from Rafael Holdings; and Scott Harris, MD of Altimmune—as they explore innovative tactics to enhance the value proposition in early-stage companies. With today’s investor environment tightening the purse strings, learn how to make every dollar work harder and smarter. Save the date: Connect with us at the CMO Summit 360° in Boston on April 8th at 12:05 PM for insights that could change the way you approach growth.

    • No alternative text description for this image
  • Running a biotech company isn’t just about breakthrough science—it’s also about having the right resources in place at the right time. At SSI Strategy, we’ve seen firsthand how aligning medical strategy with business strategy makes all the difference.   Our new white paper, "Redesigning Medical Leadership: Moving Beyond the Fractional CMO Model,"—written by former CMOs and seasoned biotech leaders—reimagines the traditional approach. Instead of relying solely on a single leader, biotech organizations can achieve greater success by investing in a structured Medical Office that not only envelops the CMO but also empowers them to focus on high-impact priorities while delegating day-to-day operational tasks to a dedicated team of experts—from regulatory professionals and clinicians to business consultants.   Key insights include: 🔹Recognizing that complex drug development demands more than a single, part-time leader. 🔹Creating a centralized partnership that bridges gaps across your organization. 🔹De-risking your assets so you can scale operations confidently.   If you’re looking for a smarter way to integrate medical and business strategies and want to see how our tailored model can work for your organization, read the white paper and let’s talk! letstalk@ssistrategy.com Read the whitepaper here: https://lnkd.in/dncr-VQV   #BiotechLeadership #MedicalOffice #CMO Steven Zelenkofske, Laurie S., Benit M., Jennifer Seda, Minna Montgomery, Carrie Brownstein, Kimberly F. Kushner, Trevor Mill, Debra Webster

    • No alternative text description for this image
  • Meet our dream team at the CMO Summit in Boston! Douglas Locke, Kimberly F. Kushner, Carrie BrownsteinJennifer Seda, Gabe Miller and Steven Zelenkofske are gearing up for the CMO Summit in Boston next month!   Our SVP, Jen Seda, will be speaking on a panel, sharing her expertise and perspectives. (More details coming soon!)    Can’t make it to the daytime sessions? Join us for a hosted Happy Hour on Monday, April 7th, at The Banks Seafood & Steak. It’s the perfect setting to unwind, network, and recap the day's highlights in a relaxed atmosphere.   Save the Date! 📍 The Banks Seafood & Steak 📆 Monday, April 7th ⏰ 6–9 PM 🔗 RSVP Here: https://lnkd.in/d6HQvc_s   We can’t wait to see you!

    • No alternative text description for this image
  • What do you think is the biggest challenge to creating a Medical Office that drives success? In our recent Build Talk video and blog post, we examined how factors like tight budgets, team integration, and long-term planning all shape the support system for the evolving CMO role. Vote below and feel free to share your challenges or additional insights in the comments! #BiotechLeadership #MedicalOffice #CMO

    This content isn’t available here

    Access this content and more in the LinkedIn app

  • As biotech companies grow, the demands on a Chief Medical Officer grow ever more complex and strong Medical Office becomes essential to support the evolving role of the CMO. In our latest blog post, “Understanding Hidden Challenges: Building a Robust Medical Office in Biotech,” we explore the obstacles leaders face when establishing a scalable support framework. From tight budgets and resource allocation to ensuring seamless integration, aligning diverse teams, and balancing day-to-day agility with long-term planning—these challenges form the foundation of building a strong Medical Office. Recognizing these hurdles is the first step toward a more resilient infrastructure that supports lasting success. Discover the full story and gain insights that will help you refine your approach. 👉 Read the full blog post on our website. https://lnkd.in/dbz7RZ3y #BiotechLeadership #MedicalOffice #CMO

    • No alternative text description for this image

Similar pages

Browse jobs

Funding